Importantly, we found that some of the above-mentioned genes (i.e., MAT2A, AHCY, MTR and MTAP) were upregulated in MGUS and smouldering myeloma patients as compared to healthy individuals. This evidence concerns the gene MTR and plasma cell myeloma.